Key result
CSP score predicts in-hospital mortality, identifying a high-risk group with ~67% mortality.
Why the study?
Existing mortality prediction scores for cardiogenic shock do not account for nonlinear clinical courses and factors during acute care management.
Can the CSP score accurately predict in-hospital mortality in adult patients with cardiogenic shock?
Observational (n=311)
Can the CSP score accurately predict in-hospital mortality in adult patients with cardiogenic shock?
The CSP score is a novel, validated nomogram that accurately predicts in-hospital mortality in patients presenting with cardiogenic shock.
CSP score may aid mortality stratification; observational data leave open prospective validation before clinical adoption.
Background Cardiogenic shock (CS) is a critical condition and the leading cause of mortality after acute myocardial infarction (AMI). Scores that predict mortality have been established, but a patient's clinical course is often nonlinear. Thus, factors present during acute care management may be explored. This study intended to develop a risk-predictive model for patients with CS. Methods In this observational study, adult patients who received inotropic support at the Emergency Room (ER) from January 2017 to August 2020 and were admitted to the cardiac care unit (CCU) with a diagnosis of CS were enrolled in this study. Patients with out-of-hospital cardiac arrest, inotropic support for bradycardia, and survival <24 h after ER arrival were excluded. A total of 311 patients were enrolled and categorized into derivation (n = 243) and validation (n = 68) cohorts. Results A history of coronary artery disease, multiple inotrope use, ejection fraction <40%, lower hemoglobin concentration, longer cardiopulmonary resuscitation duration, albumin infusion, and renal replacement therapy were identified as independent prognostic factors for in-hospital mortality. The cardiogenic shock prognosis (CSP) score was established as a nomogram and three risk groups were identified: low-risk (score 115, 0% of mortality), medium-risk (score 116–209, 8.75% of mortality), and high-risk (score 210, 66.67% of mortality). The area-under-the-curve (AUC) of the CSP score was 0.941, and the discrimination value in the validation cohort was consistent (AUC = 0.813). Conclusions The CSP score represents a risk-predictive model for in-hospital mortality in patients with CS in acute care settings. Patients identified as the high-risk category may have a poor prognosis.
No takes yet. Share an insight, caveat, or question.
Tien et al. (2022) conducted an observational in Cardiogenic shock (n=311). Cardiogenic shock prognosis (CSP) score was evaluated on in-hospital mortality (AUC 0.941). The CSP score predicted in-hospital mortality with an AUC of 0.941 in the derivation cohort and 0.813 in validation, stratifying patients into low (0%), medium (8.8%), and high-risk (66.7%) groups.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: